Gilead Sciences Posts Higher 4Q Profit
February 04 2020 - 4:48PM
Dow Jones News
By Kimberly Chin
Gilead Sciences Inc.'s (GILD) profit rose in the latest quarter
due to favorable tax benefits and an increase in net gains from
equity securities.
The biopharmaceutical company said its fourth-quarter net income
was $2.7 billion, compared with $3 million a year earlier. On a
GAAP basis, earnings were $2.12 a share for the quarter. Excluding
special items, the company posted an adjusted profit of $1.30 a
share. Analysts polled by FactSet were expecting adjusted earnings
of $1.67 a share.
Total revenue rose to $5.88 billion from $5.8 billion. Analysts
estimated $5.72 billion in revenue.
Write to Kimberly Chin at kimberly.chin@wsj.com
(END) Dow Jones Newswires
February 04, 2020 16:33 ET (21:33 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024
